Helicobacter pylori infection and gastric cancer

Japan Medical Association Journal

Volumn 48, Issue 10, 2005, Pages 497-504

  Suzuki, Hidekazu ^a,b   Nishizawa, Toshihiro ^a   Masaoka, Tatsuhiro ^a   Mori, Mikiji ^a   Iwasaki, Eisuke ^a   Tsuchimoto, Kanji ^b   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO INSTITUTE HOSPITAL   (Japan)

Author keywords

Gastric atrophy; Gastric cancer; Gastric fundic gland; Helicobacter pylori; Intestinal metaplasia; Preneoplastic lesion

Indexed keywords

GROWTH HORMONE SECRETAGOGUE RECEPTOR; HEAT SHOCK PROTEIN 60; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTESTINAL TREFOIL FACTOR; LYMPHOTOXIN; MORPHOGEN; OUTER MEMBRANE PROTEIN; PEPSINOGEN I; PEPSINOGEN II; PEROXYNITRITE; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR RUNX3; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ATROPHIC GASTRITIS; BACTERIAL COLONIZATION; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CANCER GROWTH; CANCER RISK; CLINICAL TRIAL; DISEASE ASSOCIATION; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; JAPAN; MALIGNANT TRANSFORMATION; MEDICAL RESEARCH; NONHUMAN; PATHOGENESIS; PERSISTENT INFECTION; PRECANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH FUNDUS; STOMACH MUCOSA;

EID: 29644433447     PISSN: 13468650     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;i:1273-1275.
2. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311-1315.
3. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust. 1985;142:436-439.
4. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol. 1987;82:192-199.
5. Bizzozero G. Ueber die schlauchformigen dursen des magendarmkanals und die beziehungen ihres epithels zu dem obertflachenepithel der schleimhaut. Arch fur Mikr Anat. 1893; 42:82-152.
6. Kasai K, Kobayashi R. The stomach spirochete occurring in mammals. J Parasitol. 1919;6:1-10.
7. Palmer ED. Investigation of the gastric mucosal spirochetes of the human. Gastroenterology. 1954;27:218-220.
8. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Bmj. 1991;302:1302-1305.
9. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991;325:1132-1136.
10. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127-1131.
11. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology. 1998;115:642-648.
12. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res. 1998;58:4255-4259.
13. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Metaanalysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology. 2003;125:1636-1644.
14. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-789.
15. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. Jama. 2004;291:187-194.
16. Take S, Mizuno M, Ishiki K, et al. The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol. 2005; 100:1037-1042.
17. Yamagata H, Kiyohara Y, Aoyagi K, et al. Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama study. Arch Intern Med. 2000;160:1962-1968.
18. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:639-642.
19. Nozaki K, Shimizu N, Ikehara Y, et al. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci. 2003;94:235-239.
20. Saito D. [Present state of Japanese intervention trial of H. pylori]. Nippon Rinsho. 2003;61:50-55.
21. Suzuki M, Miura S, Suematsu M, et al. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury. Am J Physiol. 1992;263:G719-725.
22. Suzuki H, Miura S, Suzuki M, Terada S, Nakamura M, Tsuchiya M. Gastric mucosal injury: microcirculation and Helicobacter pylori. Keio J Med. 1994;43:1-8.
23. Suzuki H, Mori M, Suzuki M, Sakurai K, Miura S, Ishii H. Extensive DNA damage induced by monochloramine in gastric cells. Cancer Lett. 1997;115:243-248.
24. Suzuki H, Seto K, Mori M, Suzuki M, Miura S, Ishii H. Monochloramine induced DNA fragmentation in gastric cell line MKN45. Am J Physiol. 1998;275:G712-716.
25. Suzuki H, Mori M, Seto K, Polaprezinc, a gastroprotective agent: attenuation of monochloramine-evoked gastric DNA fragmentation. J Gastroenterol. 1999;34(Suppl 11):43-46.
26. Suzuki H, Ishii H. Role of apoptosis in Helicobacter pylori-associated gastric mucosal injury. J Gastroenterol Hepatol. 2000;15(Suppl):D46-54.
27. Yamaoka Y, Kwon DH, Graham DY. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA. 2000;97:7533-7538.
28. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer. 2004;4:688-694.
29. Houghton J, Macera-Bloch LS, Harrison L, Kim KH, Korah RM. Tumor necrosis factor alpha and interleukin 1beta up-regulate gastric mucosal Fas antigen expression in Helicobacter pylori infection. Infect Immun. 2000;68:1189-1195.
30. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398-402.
31. Hsu PI, Li CN, Tseng HH. et al. The interleukin-1 RN polymorphism and Helicobacter pylori infection in the development of duodenal ulcer. Helicobacter. 2004;9:605-613.
32. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet. 1975;2:58-60.
33. Gilverry JM, Leen E, Sweeney E. The long-term effect of Helicobacter pylori on gastric mucosa. Eur J Gastroenterol Hepatol. 1994;6:43-45.
34. Sakaki N, Kozawa H, Egawa N, Tu Y, Sanaka M. Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings. Aliment Pharmacol Ther. 2002;16(Suppl 2):198-203.
35. Suzuki H, Minegishi Y, Nomoto Y, et al. Down-regulation of a morphogen (sonic hedgehog) gradient in the gastric epithelium of Helicobacter pylori-infected Mongolian gerbils. J Pathol. 2005;206:186-197.
36. van den Brink GR, Hardwick JC, Nielsen C, et al. Sonic hedgehog expression correlates with fundic gland differentiation in the adult gastrointestinal tract. Gut. 2002;51:628-633.
37. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science. 2004;306:1568-1571.
38. -/- gastric epithelial cells differentiate into intestinal type cells. Biochem Biophys Res Commun. 2004;321:58-64.
39. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660.
40. Suzuki H, Masaoka T, Hosoda H, et al. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut. 2004;53:187-194.
41. Suzuki H, Masaoka T, Hosoda H, et al. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio - a possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterology. 2004;51:1249-1254.
42. Masaoka T, Suzuki H, Imaeda H, et al. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication. Hepatogastroenterology. 2005;52:1-4.
43. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241.